Author

Shuting Lin

China Pharmaceutical UniversityORCID 0000-0002-9142-7709Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alice S.T. WongiD· 1 shared Baoping LianiD· 1 shared Canhui Yi· 1 shared Fanzhen Meng· 1 shared Hung-Cheng Lai· 1 shared Jiaxuan CheniD· 1 shared Karen K. L. ChaniD· 1 shared Ling PengiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alice S.T. WongORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Bola-amphiphilic dendrimer empowers imatinib to target metastatic ovarian cancer stem cells via beta-catenin-HRP2 signaling axis

Zeyu Shi, Margarita Artemenko, Weiyu Yu, Ming Zhang, Canhui Yi, Peng Chen, Shuting Lin, Zhancun Bian, Baoping Lian, Fanzhen Meng, Jiaxuan Chen, Tom Roussel, Ying Li, Karen K. L. Chan, Philip P.C. Ip, , Alice S.T. Wong

This study develops a nanoformulation Bola/IM to target metastatic ovarian cancer stem cells via the beta-catenin-HRP2 signaling axis, showing improved efficacy and synergy with cisplatin.

ACS Applied Materials & Interfaces · Jan 3, 2025Peer-reviewedCancer Biology